CHARLES & KEITH continues its remarkable global expansion, reinforcing its status as a leading fashion brand by opening three ...

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual ...

Osisko Announces Agreement to Purchase Royalties on Spartan Resources' Dalgaranga Gold Project in Western Australia ...

CamScanner Celebrates National Techies Day with Powerful AI Features and Campus Empowerment Program ...

-- Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in ...

Integer Holdings Corporation to Divest Non-Medical Business for $50 million ...

Epilepsy Foundation announced today it has awarded $200,000 in funding for two startups who competed in the Foundation's 2024 ...

Thermore presents Invisiloft®: the innovative slim insulation offering high warmth with minimal thickness ...

Notice to General Meeting to be held 22 October 2024. See attached announcement 371.

As part of the investment, Personal AI will partner with BDev Ventures' proprietary lead generation platform, WinDifferent, ...

BridgeBio Completes Enrollment of FORTIFY, Phase 3 Registrational Study of BBP-418 in Limb-girdle Muscular Dystrophy Type ...

Altimmune Completes Enrollment in Phase 2b IMPACT Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis ...